This important study presents convincing findings on creating an exhaustive library of new enhancer-AAVs targeting astrocytes and oligodendrocytes with high potential for both basic and translational ...
Certain graphics on this page may be affected by ad-blocking software. If portions of the page appear blank and an ad blocker is enabled, please disable the ad blocker and refresh the page to ensure ...
Researchers announce breakthrough results for AMT-130, the first disease-modifying treatment for Huntington's disease, with FDA approval application planned for early next year.